VirExit Technologies

VirExit Technologies OCF Margin

The Operating Cash Flow Margin of VirExit Technologies (VXIT) as of Nov 4, 2026 is -3,800.73 %. In the previous year, Operating Cash Flow Margin was -130.77 % — a change of 2,806.45% (lower).

OCF Margin

-3,800.73 %

YoY

2,806.45%

Last updated:

Operating Cash Flow Margin of VirExit Technologies is 2022 -3,800.73 % . Operating Cash Flow Margin of VirExit Technologies was 2021 -130.77 % . It decreases by 2,806.45% lower compared to the previous year.

The VirExit Technologies OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2016
-236.52 USD
Jan 1, 2017
-3,602.14 USD
Jan 1, 2019
-130.77 USD
Jan 1, 2022
-3,800.73 USD
The VirExit Technologies OCF Margin history
YEAROCF MarginYoY
-3,800.73 %+2,806.45%
-130.77 %-96.37%
-3,602.14 %+1,422.99%
-236.52 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

VirExit Technologies Stock analysis

What does VirExit Technologies do? VirExit Technologies, Inc. generates revenue through its branded products and services, including disinfectant cleaners, antiviral medications, personal protective equipment (PPE), and sterilization systems under the VirExit(r) and VirExit.com brands. The company targets buyers seeking protective solutions for individual, community, and local economic needs in rural and peri-urban areas globally. Its Lexian product, an Ultraviolet-C-based device, is marketed as a sterilization system for disabling viruses and bacteria through optical diffusion. The firm operates a vertical online marketplace as a primary sales and marketing platform, connecting buyers and sellers of protective products and services. This platform serves as a single source for customers requiring disinfectants, medications, PPE, and sterilization systems. VirExit(r) and VirExit.com are the key brands driving product visibility and sales across its target segments. VirExit Technologies focuses on rural and peri-urban markets worldwide, where it incubates franchise business concepts to support local economies. The company's offerings are designed to address health and safety needs, with Lexian positioned as a specialized sterilization solution. Its business model integrates product sales, franchise incubation, and an online marketplace to serve both individual and community-level demand. VirExit Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about VirExit Technologies stock

Operating Cash Flow Margin of VirExit Technologies is -3,800.73 % in 2022.

Operating Cash Flow Margin of VirExit Technologies changed from -130.77 % to -3,800.73 %, representing a 2,806.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin VirExit Technologies since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's VirExit Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — VirExit Technologies

All Key Metrics — VirExit Technologies